Your browser doesn't support javascript.
loading
Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancer.
Sokol, E S; Feng, Y X; Jin, D X; Basudan, A; Lee, A V; Atkinson, J M; Chen, J; Stephens, P J; Frampton, G M; Gupta, P B; Ross, J S; Chung, J H; Oesterreich, S; Ali, S M; Hartmaier, R J.
Afiliação
  • Sokol ES; Foundation Medicine Inc., Cambridge. Electronic address: esokol@foundationmedicine.com.
  • Feng YX; Department of Biology, Massachusetts Institute of Technology, Cambridge.
  • Jin DX; Foundation Medicine Inc., Cambridge; Department of Biology, Massachusetts Institute of Technology, Cambridge.
  • Basudan A; University of Pittsburgh, Pittsburgh; Womens Cancer Research Center, Department of Genetics, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh.
  • Lee AV; University of Pittsburgh, Pittsburgh; Womens Cancer Research Center, Department of Pharmacology and Chemical Biology, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh.
  • Atkinson JM; University of Pittsburgh, Pittsburgh; Womens Cancer Research Center, Department of Pharmacology and Chemical Biology, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh.
  • Chen J; University of Pittsburgh, Pittsburgh; Womens Cancer Research Center, Department of Pharmacology and Chemical Biology, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh.
  • Stephens PJ; Foundation Medicine Inc., Cambridge.
  • Frampton GM; Foundation Medicine Inc., Cambridge.
  • Gupta PB; Department of Biology, Massachusetts Institute of Technology, Cambridge.
  • Ross JS; Foundation Medicine Inc., Cambridge; Upstate Medical University, Syracuse, USA.
  • Chung JH; Foundation Medicine Inc., Cambridge.
  • Oesterreich S; University of Pittsburgh, Pittsburgh; Womens Cancer Research Center, Department of Pharmacology and Chemical Biology, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh.
  • Ali SM; Foundation Medicine Inc., Cambridge.
  • Hartmaier RJ; Foundation Medicine Inc., Cambridge.
Ann Oncol ; 30(1): 115-123, 2019 01 01.
Article em En | MEDLINE | ID: mdl-30423024
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Carcinoma Lobular / Carcinoma Ductal de Mama / Resistencia a Medicamentos Antineoplásicos / Neurofibromina 1 Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Carcinoma Lobular / Carcinoma Ductal de Mama / Resistencia a Medicamentos Antineoplásicos / Neurofibromina 1 Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article